Bifidobacterium animalis/cholecalciferol/lactobacillus rhamnosus gg and Alcohol/Food Interactions
There is 1 alcohol/food/lifestyle interaction with bifidobacterium animalis / cholecalciferol / lactobacillus rhamnosus gg.
Cholecalciferol Food
Moderate Food Interaction
Consumer information for this interaction is not currently available.
MONITOR: Additive effects and possible toxicity (e.g., hypercalcemia, hypercalciuria, and/or hyperphosphatemia) may occur when patients using vitamin D and/or vitamin D analogs ingest a diet high in vitamin D, calcium, and/or phosphorus. The biologically active forms of vitamin D stimulate intestinal absorption of calcium and phosphorus. This may be helpful in patients with hypocalcemia and/or hypophosphatemia. However, sudden increases in calcium or phosphorus consumption due to dietary changes could precipitate hypercalcemia and/or hyperphosphatemia. Patients with certain disease states, such as impaired renal function, may be more susceptible to toxic side effects like ectopic calcification. On the other hand, if dietary calcium is inadequate for the body's needs, the active form of vitamin D will stimulate osteoclasts to pull calcium from the bones. This may be detrimental in a patient with reduced bone density.
MANAGEMENT: Given the narrow therapeutic index of vitamin D and vitamin D analogs, the amounts of calcium, phosphorus, and vitamin D present in the patient's diet may need to be taken into consideration. Specific dietary guidance should be discussed with the patient and regular lab work should be monitored as indicated. Calcium, phosphorus, and vitamin D levels should be kept within the desired ranges, which may differ depending on the patient's condition. Patients should also be counseled on the signs and symptoms of hypervitaminosis D, hypercalcemia, and/or hyperphosphatemia.
Bifidobacterium animalis/cholecalciferol/lactobacillus rhamnosus gg drug interactions
There are 422 drug interactions with bifidobacterium animalis / cholecalciferol / lactobacillus rhamnosus gg.
Bifidobacterium animalis/cholecalciferol/lactobacillus rhamnosus gg disease interactions
There are 6 disease interactions with bifidobacterium animalis / cholecalciferol / lactobacillus rhamnosus gg which include:
- arrhythmia
- electrolyte imbalance
- hypercalcemia
- renal dysfunction
- immunosuppression
- hepatobiliary dysfunction
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.